45 related articles for article (PubMed ID: 8627606)
1. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.
Rewcastle GW; Palmer BD; Thompson AM; Bridges AJ; Cody DR; Zhou H; Fry DW; McMichael A; Denny WA
J Med Chem; 1996 Apr; 39(9):1823-35. PubMed ID: 8627606
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitors.
Bai H; Sun J; Lei H; Zhang SQ; Yuan B; Ma M; Xin M
Drug Dev Res; 2023 Dec; 84(8):1709-1723. PubMed ID: 37732677
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Herbicidal Activity, Mode of Action, and In Silico Analysis of Novel Pyrido[2,3-
Min L; Liang W; Bajsa-Hirschel J; Ye P; Wang Q; Sun X; Cantrell CL; Han L; Sun N; Duke SO; Liu X
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959782
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1,2,4-triazoles with pyrido[2,3-
Abu-Hashem AA; Hakami O; Amri N
Heliyon; 2024 Mar; 10(5):e26735. PubMed ID: 38468950
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors.
Duan Y; Zhuang L; Xu Y; Cheng H; Xia J; Lu T; Chen Y
Bioorg Chem; 2023 Jul; 136():106535. PubMed ID: 37086581
[TBL] [Abstract][Full Text] [Related]
6. Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution.
Hayes A; Mok NY; Liu M; Thai C; Henley AT; Atrash B; Lanigan RM; Sejberg J; Le Bihan YV; Bavetsias V; Blagg J; Raynaud FI
Xenobiotica; 2017 Sep; 47(9):771-777. PubMed ID: 27618572
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity evaluation of novel pyrido[3,4-
Wei L; Malhotra SV
Medchemcomm; 2012 Oct; 3(10):1250-1257. PubMed ID: 25429348
[TBL] [Abstract][Full Text] [Related]
8. Novel Pyrido[3,2-
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1627-1628. PubMed ID: 38116408
[TBL] [Abstract][Full Text] [Related]
9. Aza-Povarov Reaction. A Method for the Synthesis of Fused Tetracyclic Chromeno[4,3-
Martín-Encinas E; Lopez-Aguileta L; Palacios F; Alonso C
J Org Chem; 2024 Jan; 89(2):1099-1107. PubMed ID: 38177107
[TBL] [Abstract][Full Text] [Related]
10. Developments of pyridodipyrimidine heterocycles and their biological activities.
Hammouda MM; Elattar KM; El-Khateeb AY; Hamed SE; Osman AMA
Mol Divers; 2024 Apr; 28(2):927-964. PubMed ID: 36840839
[TBL] [Abstract][Full Text] [Related]
11. The Landscape of Featured Metabolism-Related Genes and Imbalanced Immune Cell Subsets in Sepsis.
She H; Tan L; Zhou Y; Zhu Y; Ma C; Wu Y; Du Y; Liu L; Hu Y; Mao Q; Li T
Front Genet; 2022; 13():821275. PubMed ID: 35265105
[TBL] [Abstract][Full Text] [Related]
12. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
[TBL] [Abstract][Full Text] [Related]
13.
Kimura H; Okuda H; Ishiguro M; Arimitsu K; Makino A; Nishii R; Miyazaki A; Yagi Y; Watanabe H; Kawasaki I; Ono M; Saji H
ACS Med Chem Lett; 2017 Apr; 8(4):418-422. PubMed ID: 28435529
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Inhibition of the Epidermal Growth Factor (EGF)-Induced Response of Mutant MCF10A Cells with an Acoustic Sensor.
Garcia MP; Shahid A; Chen JY; Xi J
Biosensors (Basel); 2012 Nov; 2(4):448-64. PubMed ID: 25586035
[TBL] [Abstract][Full Text] [Related]
15. Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method.
Du H; Hu Z; Bazzoli A; Zhang Y
PLoS One; 2011; 6(7):e22367. PubMed ID: 21811593
[TBL] [Abstract][Full Text] [Related]
16. A diversity oriented, microwave assisted synthesis of N-substituted 2-hydro-4-amino-pyrido[2,3-d]pyrimidin-7(8H)-ones.
Mont N; Teixidó J; Borrell JI
Mol Divers; 2009 Feb; 13(1):39-45. PubMed ID: 19037737
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents.
Ciardiello F
Drugs; 2000; 60 Suppl 1():25-32; discussion 41-2. PubMed ID: 11129169
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.
Noonberg SB; Benz CC
Drugs; 2000 Apr; 59(4):753-67. PubMed ID: 10804033
[TBL] [Abstract][Full Text] [Related]
19. Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes.
Sekharam M; Cunnick JM; Wu J
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):751-8. PubMed ID: 10698703
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors in preclinical development.
Levitt ML; Koty PP
Invest New Drugs; 1999; 17(3):213-26. PubMed ID: 10665475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
